LGALS9 and gastric cancer: The results revealed a significant correlation between higher Gal-9 levels and improved OS in patients with gastrointestinal cancers, including esophageal and gastric cancers (HR = 0.77, 95% CI = 0.63-0.93, p = 0.007).